Self-template synthesis of mesoporous and biodegradable Fe3O4 nanospheres as multifunctional nanoplatform for cancer therapy

A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy

As a famous drug delivery system (DDS), mesoporous organosilica nanoparticles (MON) are degraded slowly in vivo and the degraded components are not useful for cell nutrition or cancer theranostics, and superparamagnetic iron oxide nanoparticles (SPION) are not mesoporous with low drug loading content (DLC). To overcome the problems of MON and SPION, we developed mesoporous SPIONs (MSPIONs) with an average diameter of 70 nm and pore size of 3.9 nm. Sorafenib (SFN) and/or brequinar (BQR) were loaded into the mesopores of MSPION, generating SFN@MSPION, BQR@MSPION and SFN/BQR@MSPION with high DLC of 11.5% (SFN), 10.1% (BQR) and 10.0% (SNF + BQR), demonstrating that our MSPION is a generic DDS. SFN/BQR@MSPION can be used for high performance ferroptosis therapy of tumors because: (1) the released Fe2+/3+ in tumor microenvironment (TME) can produce •OH via Fenton reaction; (2) the released SFN in TME can inhibit the cystine/glutamate reverse transporter, decrease the intracellular glutathione (GSH) and GSH peroxidase 4 levels, and thus enhance reactive oxygen species and lipid peroxide levels; (3) the released BQR in TME can further enhance the intracellular oxidative stress via dihydroorotate dehydrogenase inhibition. The ferroptosis therapeutic mechanism, efficacy and biosafety of MSPION-based DDS were verified on tumor cells and tumor-bearing mice.

Mesoporous Magnetic/Polymer Hybrid Nanoabsorbent for Rapid and Efficient Removal of Heavy Metal Ions from Wastewater

As an advanced water purification technology, magnetic nanoabsorbents are highly attractive for their sustainability, robustness, and energy efficiency. However, magnetic responsiveness and high adsorptive capacity are irreconcilable during the design and synthesis of a high-performance magnetic nanoabsorbent. Here, we address this issue by designing a kind of mesoporous magnetic polymer hybrid microspheres, where functional polymers such as polyrhodanine and polypyrrole were attached to the pore walls in the interior of mesoporous Fe3O4 microspheres through in situ polymerization. Due to the integrated large saturation magnetic moment, porous structure, and dense polymer layer, the mesoporous magnetic polymer hybrid microspheres demonstrated fast magnetic responsiveness, excellent recycling performance, and high adsorption capacities toward Pb(II) ions (189 mg g-1) for polyrhodanine and Cr(VI) ions (199 mg g-1) for polypyrrole. Furthermore, their potential application in wastewater treatment was verified by a self-made magnetic separation column, where the designed magnetic nanoabsorbent exhibits significant advantages including rapid separation of heavy metal ions and high outflow. This study provided a promising magnetic polymer hybrid nanoabsorbent for realizing efficient removal of heavy metal ions from wastewater.

Functional roles of magnetic nanoparticles for the identification of metastatic lymph nodes in cancer patients

Staging lymph nodes (LN) is crucial in diagnosing and treating cancer metastasis. Biotechnologies for the specific localization of metastatic lymph nodes (MLNs) have attracted significant attention to efficiently define tumor metastases. Bioimaging modalities, particularly magnetic nanoparticles (MNPs) such as iron oxide nanoparticles, have emerged as promising tools in cancer bioimaging, with great potential for use in the preoperative and intraoperative tracking of MLNs. As radiation-free magnetic resonance imaging (MRI) probes, MNPs can serve as alternative MRI contrast agents, offering improved accuracy and biological safety for nodal staging in cancer patients. Although MNPs' application is still in its initial stages, exploring their underlying mechanisms can enhance the sensitivity and multifunctionality of lymph node mapping. This review focuses on the feasibility and current application status of MNPs for imaging metastatic nodules in preclinical and clinical development. Furthermore, exploring novel and promising MNP-based strategies with controllable characteristics could lead to a more precise treatment of metastatic cancer patients.